GUARDANT HEALTH INC (GH)

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium

Sheffield United Is Latest Football Club to Agree US Takeover

An American consortium has agreed to buy Sheffield United, one of the biggest English football teams outside the Premier League.

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™

/PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company, today announced that a jury in the U.S. District...

Guardant Health Stock Sees RS Rating Jump To 83

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The rock star money manager is starting to roll with the rallying market.

Why Guardant Health Stock Blasted 13% Higher on Thursday

Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop

The company also hiked its outlook for the year and guided to 20% growth in clinical volumes next year.

Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Guardant Health to Participate in Upcoming Investor Conferences

Why Guardant Health Stock Was the Picture of Health Today

There's nothing like free publicity to help goose the sales of a relatively new product.

Guardant Health Named to TIME’s List of the Best Inventions of 2024

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024

Roberto A. Mignone Joins Guardant Health Board of Directors

Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024

Guardant Health Enters Oversold Territory (GH)

GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long

Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types

Notable Wednesday Option Activity: GWW, WHR, GH

GH Makes Bullish Cross Above Critical Moving Average

Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy

Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Why Guardant Health Stock Just Crashed 10%

Guardant Health needs cash. Until it can get it from selling enough services, it must sell its own shares instead.

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor is making moves this summer.

Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor was a buyer at the end of a very volatile trading week.